Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.2.40 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Yaoyao Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Shandong First Me…. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Toll-Like Receptor 4, Wound Healing, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Purpose
Diabetic keratopathy (DK) is a significant ocular surface complication of diabetes. This study investigated the role of advanced glycation end-products (AGEs) in DK pathogenesis and the underlying mechanism.
Methods
Type I diabetes mellitus (T1DM) mouse model was established by intraperitoneal injection of streptozotocin to assess AGE accumulation and inflammatory factor expression in corneal tissues. A bone marrow-derived dendritic cell (BMDC) culture platform, RNA sequencing (RNA-seq), and pharmacological interventions were used to examine AGE-induced inflammatory response and signaling pathways. The impact of Toll-like receptor 4 (TLR4) signaling (blocked by TAK-242) and AGE formation (inhibited by pyridoxamine [PM]) on diabetic corneal epithelial wound healing (CEWH) was evaluated.
Results
Compared with untreated controls, AGE-challenged BMDCs exhibited an exacerbated inflammatory response and increased phosphorylation of nuclear factor kappa-B (NF-κB) p65 and interferon regulatory factor 3 (IRF3). TLR4 blockade with TAK-242 significantly attenuated this inflammation and reduced phosphorylation of p65 and IRF3. RNA-seq analysis revealed baseline low-grade inflammation and hyper-phosphorylation of p65 and IRF3 in advanced diabetic corneas with AGE accumulation. Topical TAK-242 treatment significantly reversed delayed CEWH and accelerated corneal nerve regeneration in T1DM mice. Similarly, inhibiting AGE formation with PM also expedited diabetic CEWH and nerve regeneration.
Conclusions
The AGE/TLR4 axis drives sustained corneal inflammation by activating p65 and IRF3, thereby promoting DK progression. These findings identify AGE/TLR4 signaling as a potential therapeutic target for DK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Shandong First Medical University, Qingdao, China.
- Qingdao Eye Hospital of Shandong First Medical University, Shandong First Medical University, Qingdao, China.
- School of Ophthalmology, Shandong First Medical University, Jinan, China.
- Department of Ophthalmology, Fujian Medical University Union Hospital, Fu Zhou, China.
Zitieren
APA
Yu, Y., Zhang, Y., Tang, Y., Ma, L., Wei, C., & Bai, X. (2026). Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.2.40
Vancouver
Yu Y, Zhang Y, Tang Y, Ma L, Wei C, Bai X. Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.2.40
BibTeX
@article{Yu2026,
author = {Yu, Yaoyao and Zhang, Yani and Tang, Yang and Ma, Li and Wei, Chao and Bai, Xiaofei},
title = {Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.2.40}
}
EUVIMED